MedPage Today on MSN
Base-Editing Gene Therapy Shows Promise in Sickle Cell Disease
Durable expression of anti-sickling fetal hemoglobin and reduction in sickle hemoglobin ob ...
USA: In an interim analysis of the phase I/II BEACON study, treatment with ristoglogene autogetemcel (risto-cel) demonstrated ...
Prestigious Publication Reinforces risto-cel’s Durable, Differentiated Clinical Data for the Treatment of SCD with Severe ...
Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust ...
Key points Sickle cell disease (SCD) occurs when a DNA base pair substitution in the β-globin gene results in the formation of hemoglobin S, which polymerizes when deoxygenated, leading to deformation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results